Beck Depression Inventory for Primary Care

1997 ◽  
Author(s):  
Aaron Beck ◽  
David Guth ◽  
Robert A. Steer ◽  
Roberta Ball
Keyword(s):  
Primary Care ◽  
Beck Depression Inventory

USE OF THE CHINESE VERSION OF THE BECK DEPRESSION INVENTORY FOR SCREENING DEPRESSION IN PRIMARY CARE

2002 ◽  
Vol 190 (2) ◽  
pp. 94-99 ◽  
Author(s):  
ALBERT YEUNG ◽  
SHAUNA HOWARTH ◽  
RAYMOND CHAN ◽  
SHAMSAH SONAWALLA ◽  
ANDREW A. NIERENBERG ◽  
...  
Keyword(s):  
Primary Care ◽  
Beck Depression Inventory ◽  
Chinese Version

scholarly journals Cognitive–behavioural therapy v. usual care in recurrent depression

2008 ◽  
Vol 193 (6) ◽  
pp. 505-506 ◽  
Author(s):  
Henk Jan Conradi ◽  
Peter de Jonge ◽  
Johan Ormel
Keyword(s):  
Primary Care ◽  
Usual Care ◽  
Beck Depression Inventory ◽  
Cognitive Behavioural Therapy ◽  
Acute Phase ◽  
Behavioural Therapy ◽  
Recurrent Depression ◽  
Cognitive Behavioural ◽  
Cognitive Problems

SummaryWe examined in a primary care sample whether acute-phase cognitive–behavioural therapy (CBT) would be more effective than usual care for patients with multiple prior episodes of depression. Depression outcome was based on a 3-monthly administered Beck Depression Inventory (BDI) during a 2-year follow-up. We confirmed that in patients with four or more prior episodes, CBT outperformed usual care by four points on the BDI, but not in patients with three or fewer prior episodes. Subsequent analyses suggested that CBT may be able to tackle cognitive problems related to rumination in patients with recurrent depression.

To Screen or Not to Screen: Symptoms Identifying Primary Care Medical Patients in Need of Screening for Depression

1998 ◽  
Vol 28 (3) ◽  
pp. 293-302 ◽  
Author(s):  
Cheryl N. Carmin ◽  
John W. Klocek
Keyword(s):  
Primary Care ◽  
Beck Depression Inventory ◽  
Primary Care Physicians ◽  
Depressive Symptomatology ◽  
Primary Care Clinic ◽  
Office Visit ◽  
Medical Patients ◽  
Care Clinic ◽  
Professional Mental Health ◽  
Primary Care Patients

Objective: It is estimated that 5 percent to 10 percent of primary care patients meet criteria for Major Depressive Disorder with an additional 10 percent to 30 percent experiencing significant subclinical depression. However, only 18 percent to 50 percent of depressed primary care patients are so diagnosed by their primary care physicians and even fewer receive professional mental health care. The current study proposes a quick and efficient means to assist physicians in determining for which patients the resource intensive process of thoroughly screening for depression should be engaged. Method: The present study examined responses of 358 consecutively reporting patients to a midwest university-based primary care clinic on the Beck Depression Inventory. Results: Among individuals reporting high levels of depressive symptomatology, five questions from the Beck Depression Inventory were endorsed by 90 percent or greater of the participants. Analyses by gender indicated that while the same five items were endorsed by males and females, three additional items were frequently endorsed by males. Conclusions: These findings suggest that a means for efficiently identifying individuals who warrant screening for depression may be readily available to primary care physicians. Surprisingly, this screening was found to emphasize psychological rather than vegetative symptoms. Thus, attending to these symptoms and/or complaints during the course of an office visit may serve as an indicator that a thorough screening for depression, or possibly referral, is warranted.

Use of the Beck Depression Inventory-II with African American primary care patients

2004 ◽  
Vol 26 (6) ◽  
pp. 437-442 ◽  
Author(s):  
Gareth R. Dutton ◽  
Karen B. Grothe ◽  
Glenn N. Jones ◽  
Dori Whitehead ◽  
Kathleen Kendra ◽  
...  
Keyword(s):  
Primary Care ◽  
African American ◽  
Beck Depression Inventory ◽  
Primary Care Patients

Laser Acupuncture for Mild to Moderate Depression in a Primary Care Setting – a Randomised Controlled Trial

2005 ◽  
Vol 23 (3) ◽  
pp. 103-111 ◽  
Author(s):  
Joo Im Quah-Smith ◽  
Wai Mun Tang ◽  
Janice Russell
Keyword(s):  
Primary Care ◽  
Randomised Controlled Trial ◽  
Beck Depression Inventory ◽  
Controlled Trial ◽  
Laser Acupuncture ◽  
Control Group ◽  
Major Public Health Problem ◽  
Sham Control ◽  
Moderate Depression ◽  
Randomised Controlled

Objective Depression is a major public health problem. There is some evidence supporting the effectiveness of needle acupuncture in its treatment. Laser stimulation, regarded here as a modality of acupuncture, is non-invasive and therefore free of infection risk; and it is acceptable to patients with needle phobia. The technique is relatively easily learned by community-based general practitioners. It is also amenable to sham control and therefore double-blinding in clinical trials. A double-blind randomised controlled trial was conducted to test the efficacy of low level laser acupuncture in mild to moderate depression. Methods Thirty patients with depression were randomised to receive either active or inactive laser treatment. The laser unit could be switched to one of two settings. One switch position delivered active laser acupuncture and the other was inactive (sham). In the active mode, 0.5J was delivered to each of six to eight individually tailored acupuncture sites per visit. All patients were treated twice weekly for four weeks then weekly for a further four weeks. The patients and the acupuncturist were both blinded to conditions. Outcome was assessed using the Beck Depression Inventory at baseline, weeks four and eight during treatment, and at 4 and 12 weeks following the treatment. Results At the end of the treatment period, Beck Depression Inventory scores fell from baseline by 16.1 points in the intervention group and by 6.8 points in the sham control group (P<0.001). The difference showed only a trend four weeks later, but was again significant after 12 weeks (P=0.007). Laser acupuncture was well tolerated with transient fatigue as the most common adverse effect. Conclusion Laser acupuncture may be worth further investigation as a treatment for mild to moderate depression in primary care.

scholarly journals Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)

BMJ ◽  
2018 ◽  
pp. k4218 ◽  
Author(s):  
David S Kessler ◽  
Stephanie J MacNeill ◽  
Deborah Tallon ◽  
Glyn Lewis ◽  
Tim J Peters ◽  
...  
Keyword(s):  
Primary Care ◽  
Adverse Effects ◽  
Confidence Interval ◽  
Beck Depression Inventory ◽  
Reuptake Inhibitor ◽  
Controlled Trial ◽  
Phase Iii ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Resistant Depression

AbstractObjectiveTo investigate the effectiveness of combining mirtazapine with serotonin-noradrenaline reuptake inhibitor (SNRI) or selective serotonin reuptake inhibitor (SSRI) antidepressants for treatment resistant depression in primary care.DesignTwo parallel group multicentre phase III randomised placebo controlled trial.Setting106 general practices in four UK sites; Bristol, Exeter, Hull, and Keele/North Staffs, August 2013 to October 2015.Participants480 adults aged 18 or more years who scored 14 or more on the Beck depression inventory, second revision, fulfilled ICD-10 (international classification of diseases, 10th revision) criteria for depression, and had used an SSRI or SNRI for at least six weeks but were still depressed. 241 were randomised to mirtazapine and 239 to placebo, both given in addition to usual SSRI or SNRI treatment. Participants were stratified by centre and minimised by baseline Beck depression inventory score, sex, and current psychological therapy. They were followed up at 12, 24, and 52 weeks. 431 (89.8%) were included in the (primary) 12 week follow-up.Main outcome measuresDepressive symptoms at 12 weeks after randomisation, measured using the Beck depression inventory II score as a continuous variable. Secondary outcomes included measures of anxiety, quality of life, and adverse effects at 12, 24, and 52 weeks.ResultsBeck depression inventory II scores at 12 weeks were lower in the mirtazapine group after adjustment for baseline scores and minimisation or stratification variables, although the confidence interval included the null (mean (SD) scores at 12 weeks: 18.0 (12.3) in the mirtazapine group, 19.7 (12.4) in the placebo group; adjusted difference between means −1.83 (95% confidence interval −3.92 to 0.27); P=0.09). Adverse effects were more common in the mirtazapine group and were associated with the participants stopping the trial drug.ConclusionThis study did not find evidence of a clinically important benefit for mirtazapine in addition to an SSRI or SNRI over placebo in a treatment resistant group of primary care patients with depression. This remains an area of important unmet need where evidence of effective treatment options is limited.Trial registrationCurrent Controlled TrialsISRCTN06653773.

Detection and Prevalence of Depressive Disorders in Primary Care Settings in Hungary

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
P. Torzsa ◽  
X. Gonda ◽  
N. Szokontor ◽  
B. Sebestyen ◽  
G. Faludi ◽  
...  
Keyword(s):  
Primary Care ◽  
Beck Depression Inventory ◽  
Depressive Episode ◽  
Depressive Disorders ◽  
Major Depressive Episode ◽  
Care Service ◽  
Health Care Service ◽  
Major Depressive ◽  
Current Prevalence ◽  
Dsm Iv

Background:Although depressive disorders are common conditions in primary health care service, and many depressed patients consult their general practitioners, GPs have some difficulties in the detection and correct diagnosis of depression. Unrecognized and untreated depression causes great health and economic burden and also contributes to significant suffering, therefore the correct recognition of affective disorder in GP settings is an important healthcare target. The aim of our study was to assess the prevalence of depressive disorders in general practices in Hungary and also to assess the sensitivity and specificity of different depression screening instruments.Method:In the present study the current prevalence of DSM-IV depressive disorders were surveyed among 984 primary care attendees in 6 GP practices in Hungary, using the Beck Depression Inventory and the PRIME-MD screening instrument.Results:The current prevalence rate of any PRIME-MD DSM-IV depressive disorders, including symptomatic major depressive episode, were 18.5% and 7.3% respectively. Beck Depression Inventory identified any current depressive disorders with 95% sensitivity and 56% specificity and the same figures for current symptomatic major depressive episode were 83% and 23%, respectively.Discussion:Our results are similar to those reported previously from Hungary and from other countries. The findings also indicate that the Beck Depression Inventory and PRIME-MD can help in detecting depressive disorders in primary care.

Sign in / Sign up

Export Citation Format

Share Document